24
Participants
Start Date
December 12, 2023
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
PGN-EDODM1 for infusion
Single dose of PGN-EDODM1 by intravenous (IV) infusion
Placebo
Administered by IV infusion
University of Rochester Medical Center, Rochester
Virginia Commonwealth University, Richmond
Rare Disease Research, Atlanta
University of Kansas Medical Center, Fairway
UCI Center for Clinical Research, Irvine
Stanford University, Palo Alto
Massachusetts General Hospital, Boston
University of Calgary, Calgary
Ottawa Hospital Research Institute (OHRI), Ottawa
CIUSSS du Saguenay-Lac-Saint-Jean, Chicoutimi
Salford Royal Hospital, Salford
University College London Hospital, London
Lead Sponsor
PepGen Inc
INDUSTRY